MedTrace Logo

Cost-Effectiveness of Amphotericin B

NCT02527928 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2015-08-19

No results posted yet for this study

Summary

Invasive fungal infections (IFIs) are complications that happen in the hospital, usually in patients hospitalized for long periods in intensive care units (ICU) after invasive procedures, and in specific populations, such as cancer patients. The aim of this study is to determine the direct and indirect hospital costs with different formulations of amphotericin B (deoxycholate, lipid complex and liposomal) in different public and private hospitals in the city of Curitiba, Paraná, Brazil.

Conditions

  • Invasive Fungal Infections

Interventions

OTHER

None intervention

Sponsors & Collaborators

  • Hospital Universitario Evangelico de Curitiba

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-09-30
Primary Completion
2015-12-31
Completion
2016-02-29

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02527928 on ClinicalTrials.gov